Trials / Recruiting
RecruitingNCT05388682
Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Chinese Pulmonary Vascular Disease Research Group · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement
Detailed description
At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu arteritis with pulmonary artery involvement.
Conditions
- Takayasu Arteritis With Pulmonary Artery Involvement
- Percutaneous Transluminal Pulmonary Angioplasty
- PAH Targeted Medication
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous transluminal pulmonary angioplasty | Percutaneous transluminal pulmonary angioplasty |
Timeline
- Start date
- 2014-01-19
- Primary completion
- 2042-12-31
- Completion
- 2042-12-31
- First posted
- 2022-05-24
- Last updated
- 2023-12-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05388682. Inclusion in this directory is not an endorsement.